Bladder Cancer Trial, Recruiting NCT05002556 Sponsor: Association Francaise d'Urologie Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT05002556
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are being monitored for a type of bladder tumour that has not grown into the bladder muscle, and who had a urine-based biomarker test before their surgical removal or diagnosis of a returning tumour
  • People who are 18 years of age or older
  • People who are enrolled in the French social security system
  • People whose ongoing monitoring will take place at the centre running this trial

Who may not be able to join:

  • People being monitored for a bladder tumour that is not of the urothelial type (the most common bladder cell type)
  • People who do not wish to continue with the required follow-up appointments
  • People who do not want to take part in the study
  • Adults who are legally protected (for example, those under guardianship or a similar legal protection arrangement)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33145480609

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Association Francaise d'Urologie
Registry
ClinicalTrials.gov
Start date
21 February 2023
Est. completion
1 February 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Recurrence-Free Survival; Performance of urine tests (biomarkers)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov